PHYOF.US IXICO plc

Healthcare Biotechnology USA Stocks
0.7700 USD
Close of Nov 15, 2026
0.0700 0.0700
Market cap
USD 169M
P/E
-
P/B
0.26x
ROE
-42.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2026.

Is PHYOF.US undervalued?

Graham number

The Graham number of IXICO plc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

IXICO plc fundamental analysis

No fundamental analysis for IXICO plc yet.

IXICO plc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About IXICO plc

IXICO plc provides data analytics services to biopharmaceutical industry in the United States, the United Kingdom, the Netherlands, Denmark, Switzerland, Ireland, Europe, and internationally. The company offers collection, analysis, management, and reporting on gathered clinical study data; neurological diseases data collection and analysis; and sales and marketing services. It also provides imaging contract research organization solutions, including imaging biomarkers, such…

Full company profile